DRMAW Dermata Therapeutics, Inc.

Fundamentals / CIK 0001853816 / USD
Other share classes on CIK 0001853816: DRMA

Dermata Therapeutics, Inc. reported $6.64M in total assets and a net loss of $9.50M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open DRMAW in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$0$0$0-$11.49MFY 2020 Net Income: -$3.24M2020FY 2021 Net Income: -$7.90M2021FY 2022 Net Income: -$9.61M2022FY 2023 Net Income: -$7.79M2023FY 2024 Net Income: -$12.29M2024FY 2025 Net Income: -$7.56M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $2.93M $8.20M $4.07M $5.65M $3.46M $1.61M
Selling, General & Admin $4.84M $4.31M -- -- -- --
Total Operating Expenses $7.77M $12.51M $8.04M $9.67M -- --
Operating Income -$7.77M -$12.51M -$8.04M -$9.67M -$7.86M -$3.17M
EBITDA -- -- -- -- -$7.86M -$3.17M
Interest Income $215K $226K $247K $64K -- --
Interest Expense -- -- -- -- $46K $197K
Income Tax Expense -- $0 $0 $0 $0 $0
Net Income -$7.56M -$12.29M -$7.79M -$9.61M -$7.90M -$3.24M
Basic EPS -$8.16 -$80.32 -$399.90 -$139.20 -$24.30 -$16.90
Diluted EPS -$8.16 -$80.32 -$399.90 -- -- --
Basic Shares Outstanding 926.2K 153.0K -- -- 430.2K 191.1K
Diluted Shares Outstanding 926.2K 153.0K 19.5K -- -- --

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $74K -- -- -- -- -- -- --
Cost of Revenue $34K -- -- -- -- -- -- --
Gross Profit $40K -- -- -- -- -- -- --
Research & Development $143K $213K $384K $527K $504K $618K $1.28M $2.19M
Selling, General & Admin $2.76M $2.80M $1.54M $1.37M $1.26M $1.15M $1.06M --
Total Operating Expenses $2.90M $3.01M $1.93M $1.90M $1.76M $1.77M $2.34M $3.20M
Operating Income -$2.86M -$3.01M -$1.93M -$1.90M -$1.76M -$1.77M -$2.34M -$3.20M
Interest Income $37K $47K $79K $39K $69K $72K $36K $49K
Net Income -$2.82M -$2.97M -$1.85M -$1.86M -$1.69M -$1.70M -$2.30M -$3.15M
Basic EPS -$0.55 -$0.74 -$0.48 -- -$1.65 -$1.22 -$4.47 --
Diluted EPS -$0.55 -$0.74 -$0.48 -- -$1.65 -$1.66 -$4.47 --
Basic Shares Outstanding 5.1M 4.0M 3.9M -- 1.0M 1.0M 515.5K --
Diluted Shares Outstanding 5.1M 4.0M 3.9M -- 1.0M 1.0M 515.5K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $7.52M $3.16M -- $6.24M $10.80M $530K
Cash & Short-Term Investments $7.52M $3.16M -- $6.24M $10.80M $530K
Total Current Assets $7.86M -- -- -- $11.62M $605K
Property, Plant & Equipment, Net -- -- -- -- $0 $0
Total Non-Current Assets $0 -- -- -- $0 $0
Total Assets $7.86M $3.53M $7.98M $6.94M $11.62M $605K
Accounts Payable $461K $808K $866K $497K $515K $104K
Short-Term Debt -- -- -- -- $0 $556K
Total Current Liabilities -- -- -- -- $1.52M $3.78M
Total Non-Current Liabilities -- -- -- -- $0 $0
Total Liabilities $1.64M $1.97M $1.62M $923K $1.52M $3.78M
Total Debt (incl. Leases) -- -- -- -- $0 $556K
Common Stock $266 $25 $26 $77 $833 $0
Retained Earnings -$73.23M -$65.68M -$53.39M -$45.59M -$35.98M -$28.08M
Total Stockholders' Equity $6.22M $1.56M $6.36M $6.02M $10.11M -$3.18M
Total Equity $6.22M $1.56M $6.36M $6.02M $10.11M -$3.18M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $4.82M $4.41M $6.95M $7.52M $4.66M $6.48M $9.72M $3.16M
Cash & Short-Term Investments $4.82M $4.41M $6.95M $7.52M $4.66M $6.48M $9.72M $3.16M
Inventory $825K $150K $93K -- -- -- -- --
Total Current Assets $6.43M $5.16M -- $7.86M -- -- -- --
Property, Plant & Equipment, Net $159K $129K -- -- -- -- -- --
Total Non-Current Assets $205K $165K -- $0 -- -- -- --
Total Assets $6.64M $5.32M $7.47M $7.86M $5.07M $6.64M $10.01M $3.53M
Accounts Payable $1.62M $1.12M $318K $461K $453K $414K $1.40M $808K
Total Liabilities $2.73M $1.83M $1.05M $1.64M $1.11M $1.03M $2.70M $1.97M
Common Stock $493 $402 $402 $266 $84 $64 $603 $25
Retained Earnings -$80.87M -$78.05M -$75.08M -$73.23M -$71.37M -$69.68M -$67.98M -$65.68M
Total Stockholders' Equity $3.91M $3.49M $6.41M $6.22M $3.96M $5.61M $7.30M $1.56M
Total Equity $3.91M $3.49M $6.41M $6.22M $3.96M $5.61M $7.30M $1.56M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$7.56M -$12.29M -$7.79M -$9.61M -$7.90M -$3.24M
Depreciation & Amortization -- -- -- -- $0 $322
Stock-Based Compensation $144K $658K $522K $930K $1.91M $0
Change in Payables -$388K -$109K $369K -$19K $411K -$233K
Operating Cash Flow -$7.80M -$11.16M -$6.41M -$8.83M -$5.69M -$4.03M
Common Stock Issued $12.17M $6.89M $7.61M $4.28M $15.39M --
Financing Cash Flow $12.12M $6.89M $7.61M $4.28M $15.96M $2.57M
Net Change in Cash $4.36M -$4.28M $1.20M -$4.56M $10.27M -$1.46M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$2.82M -$2.97M -$1.85M -$1.86M -$1.69M -$1.70M -$2.30M -$3.15M
Stock-Based Compensation $42K $42K $43K $29K $38K $39K $37K $30K
Change in Inventory -$676K -$57K -$93K -- -- -- -- --
Change in Payables $444K $783K -$51K -$84K $53K -$459K $102K -$98K
Operating Cash Flow -$2.65M -$2.42M -$2.48M -$1.37M -$1.80M -$2.69M -$1.93M -$2.91M
Common Stock Issued -- -- -- $4.19M -$13K -$548K $8.54M -$70K
Financing Cash Flow $3.31M -$323 $1.90M $4.19M -$13K -$548K $8.49M -$69K
Net Change in Cash $610K -$2.53M -$577K $2.86M -$1.82M -$3.24M $6.56M -$2.98M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -121.5% -787.1% -122.7% -159.6% -78.2% --
Return on Assets (ROA) -96.1% -347.7% -97.7% -138.4% -68.0% -534.6%
Current Ratio -- -- -- -- 7.66x 0.16x
Quick Ratio -- -- -- -- 7.12x 0.14x
Debt to Equity -- -- -- -- 0.00x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -243.2% -239.9% -110.8% -121.5% -223.4% -184.0% -156.9% -787.1%
Return on Assets (ROA) -143.1% -157.3% -95.1% -96.1% -174.5% -155.5% -114.5% -347.7%
Source: SEC EDGAR CompanyFacts (CIK 0001853816) · from March 31, 2020 Data through September 30, 2026 · synced Nov 21, 2026, 05:10 UTC · Open in terminal